Anthony T. Newall
NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
Erratum to "The cost of respiratory syncytial virus (RSV) across all ages to the Australian healthcare system" [Vaccine 88 (2026) 128922].
Journal: Vaccine
Published: August 10, 2026
New-onset diabetes following SARS-CoV-2 Omicron infection: a matched cohort study.
Journal: International journal of population data science
Published: August 01, 2026
The cost of respiratory syncytial virus (RSV) across all ages to the Australian healthcare system.
Journal: Vaccine
Published: April 24, 2026
The Value of Combination Vaccines in Children and Adults: More than the Sum of Their Parts.
Journal: PharmacoEconomics
Published: February 17, 2026
Respiratory syncytial virus (RSV) vaccination program for older Australians reduces health inequalities: a distributional cost-effectiveness analysis.
Journal: Vaccine
Published: December 22, 2025
A retrospective cohort study and spatial analysis of climate and community-level determinants of respiratory syncytial virus notifications among Queensland infants, prior to the introduction of the RSV mother and infant protection program (RSV-MIPP) immunisation initiative.
Journal: BMC public health
Published: September 08, 2025
New-onset diabetes following SARS-CoV-2 infection in the Omicron era: a matched cohort study.
Journal: International journal of epidemiology
Published: June 29, 2025
Estimating the cost-effectiveness of maternal respiratory syncytial virus (RSV) vaccination in Australia: A dynamic and economic modelling analysis.
Journal: Vaccine
Published: July 22, 2024
Last Updated: 09/26/2026